Search

Your search keyword '"Robert C Andrews"' showing total 158 results

Search Constraints

Start Over You searched for: Author "Robert C Andrews" Remove constraint Author: "Robert C Andrews"
158 results on '"Robert C Andrews"'

Search Results

51. Ozone/peroxide advanced oxidation in combination with biofiltration for taste and odour control and organics removal

52. Coagulation optimization for DOC removal: pilot-scale analysis of UF fouling and disinfection byproduct formation potential

54. Engineered biofiltration for the removal of disinfection by-product precursors and genotoxicity

55. Development of artificial neural networks based confidence intervals and response surfaces for the optimization of coagulation performance

56. Effects of coagulation on the removal of natural organic matter, genotoxicity, and precursors to halogenated furanones

57. Distribution of surface shear stress for a densely packed submerged hollow fiber membrane system

58. Contributions of spatial, temporal, and treatment impacts on natural organic matter character using fluorescence-based measures

59. Comparison of three-dimensional fluorescence analysis methods for predicting formation of trihalomethanes and haloacetic acids

60. The Effect of Concentration Factor on Membrane Fouling

61. Characterization of UF foulants and fouling mechanisms when applying low in-line coagulant pre-treatment

62. Comparative assessment of ceramic media for drinking water biofiltration

63. Ultrafiltration Fouling: Impact of Backwash Frequency and Air Sparging

64. Engineered biofiltration for ultrafiltration fouling mitigation and disinfection by-product precursor control

65. Rejection of pharmaceutically active and endocrine disrupting compounds by nanofiltration as a function of source water humic substances

66. Optimization of coagulant dose for biopolymer removal: Impact on ultrafiltration fouling and retention of organic micropollutants

67. Statistical significance testing of parallel pilot-scale coagulation optimization study to compare aluminum sulfate and polyaluminum chloride performance

68. Surface shear stress and retention of emerging contaminants during ultrafiltration for drinking water treatment

70. Nanofiltration of pharmaceutically active and endocrine disrupting compounds as a function of compound interactions with DOM fractions and cations in natural water

71. Assessing microbial risk through event-based pathogen loading and hydrodynamic modelling

72. Impact of low coagulant dosages on protein fouling of ultrafiltration membranes

73. Impact of natural water colloids and cations on the rejection of pharmaceutically active and endocrine disrupting compounds by nanofiltration

74. Surface shear stress and membrane fouling when considering natural water matrices

75. The impact of alum coagulation on pharmaceutically active compounds, endocrine disrupting compounds and natural organic matter

76. Removal of halo-benzoquinone (emerging disinfection by-product) precursor material from three surface waters using coagulation

77. Comparison of three corrosion inhibitors in simulated partial lead service line replacements

78. Investigation of ozone and peroxone impacts on natural organic matter character and biofiltration performance using fluorescence spectroscopy

79. Evaluation of fluorescence excitation–emission and LC-OCD as methods of detecting removal of NOM and DBP precursors by enhanced coagulation

80. The application of artificial neural networks for the optimization of coagulant dosage

81. Application of Artificial Neural Networks for Filtration Optimization

82. Practical overview of analytical methods for endocrine-disrupting compounds, pharmaceuticals and personal care products in water and wastewater

83. The influence of natural organic matter and cations on the rejection of endocrine disrupting and pharmaceutically active compounds by nanofiltration

84. The influence of natural organic matter and cations on fouled nanofiltration membrane effective molecular weight cut-off

85. RAGE Ligation Affects T Cell Activation and Controls T Cell Differentiation

86. Effect of ClO2 Pretreatment on Subsequent Water Treatment Processes

87. The rejection of endocrine disrupting and pharmaceutically active compounds by NF and RO membranes as a function of compound and water matrix properties

88. Biostability and disinfectant by-product formation in drinking water blended with UF-treated filter backwash water

90. Membrane adsorption of endocrine disrupting compounds and pharmaceutically active compounds

91. Targeting Protein Multiple Conformations: A Structure-Based Strategy for Kinase Drug Design

92. Inactivation of environmental and reference strains of heterotrophic bacteria and Escherichia coli O157:H7 by free chlorine and monochloramine

93. Impact of UV and secondary disinfection on microbial control in a model distribution system

94. Removal of endocrine disrupting compounds using a membrane bioreactor and disinfection

95. Evaluation of exposure to lead from drinking water in large buildings

96. Fluorescence spectroscopy for monitoring reduction of natural organic matter and halogenated furanone precursors by biofiltration

97. Conventional drinking water treatment and direct biofiltration for the removal of pharmaceuticals and artificial sweeteners: A pilot-scale approach

98. Factors affecting lead release in sodium silicate-treated partial lead service line replacements

99. UV inactivation of humic-coated bacteriophages MS2 and T4 in water

100. Case study comparisons of computational fluid dynamics (CFD) modeling versus tracer testing for determining clearwell residence times in drinking water treatment

Catalog

Books, media, physical & digital resources